Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II, Open-Label Study, to Assess the Long-Term Safety of Oral TMX-67 in Subjects With Gout

NCT00174941 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT00174941
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00174941 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II, Open-Label Study, to Assess the Long-Term Safety of Oral TMX-67 in Subjects With Gout
Lead sponsor
Takeda
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2001
Completion date
December 31, 2006
Enrollment
116 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

gout